• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毒蕈碱型m1受体的结合位点建模:基于同源性和间接方法的结合

Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches.

作者信息

Nordvall G, Hacksell U

机构信息

Department of Organic Pharmaceutical Chemistry, Uppsala Biomedical Center, Uppsala University, Sweden.

出版信息

J Med Chem. 1993 Apr 16;36(8):967-76. doi: 10.1021/jm00060a003.

DOI:10.1021/jm00060a003
PMID:8478909
Abstract

A model of the muscarinic m1 receptor has been constructed on the basis of the putative three-dimensional structural similarity between bacteriorhodopsin and G-protein coupled receptors. The homology-based m1 receptor model takes into account hydrophobicity and conserved amino acids and information from site-directed mutagenesis studies and from hydropathy plots. The resulting model was used in conjunction with an indirect model which describes a proposed active agonist conformation of acetylcholine and a number of related compounds. A receptor-excluded volume was constructed by superimposing these muscarinic agonists and calculating their combined van der Waals volume. The resulting m1 receptor excluded volume was used to define the agonist binding site, which consists of nine amino acids and which binds agonists primarily through interaction with Asp105 (ionic interaction). Thr192 and Asn382 (hydrogen bonds). The model is flexible since the conformation of the nine amino acids may change in response to the agonist structure. The combination of indirect and homology-based approaches is particularly attractive since it utilizes more experimental data than a purely homology-based model and since a binding-site model might be more realistic and general in terms of applicability than indirect models. Docking of the ligands was performed by optimizing attractive interactions and minimizing repulsive interactions. In addition to the agonists used to define the binding site, structurally different agonists are also accommodated by the binding-site model. Furthermore, the m1 receptor binding-site model is able to reproduce experimentally determined stereoselectivities.

摘要

基于细菌视紫红质与G蛋白偶联受体之间假定的三维结构相似性,构建了毒蕈碱m1受体模型。基于同源性的m1受体模型考虑了疏水性、保守氨基酸以及定点诱变研究和亲水性图谱提供的信息。所得模型与一个间接模型结合使用,该间接模型描述了乙酰胆碱和一些相关化合物的拟活性激动剂构象。通过叠加这些毒蕈碱激动剂并计算它们的组合范德华体积,构建了受体排除体积。所得的m1受体排除体积用于定义激动剂结合位点,该位点由九个氨基酸组成,主要通过与Asp105(离子相互作用)、Thr192和Asn382(氢键)相互作用来结合激动剂。该模型具有灵活性,因为九个氨基酸的构象可能会因激动剂结构而改变。间接方法与基于同源性的方法相结合特别有吸引力,因为它比纯基于同源性的模型利用了更多的实验数据,而且就适用性而言,结合位点模型可能比间接模型更现实、更通用。通过优化吸引相互作用和最小化排斥相互作用来进行配体对接。除了用于定义结合位点的激动剂外,结合位点模型还能容纳结构不同的激动剂。此外,m1受体结合位点模型能够重现实验确定的立体选择性。

相似文献

1
Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches.毒蕈碱型m1受体的结合位点建模:基于同源性和间接方法的结合
J Med Chem. 1993 Apr 16;36(8):967-76. doi: 10.1021/jm00060a003.
2
Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.1,4,5,6-四氢嘧啶和2-氨基-3,4,5,6-四氢吡啶衍生物作为选择性M1激动剂的合成及生物学特性研究
J Med Chem. 1997 Apr 11;40(8):1230-46. doi: 10.1021/jm960467d.
3
Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.2-氨基四氢萘与人多巴胺D2A和D3受体结合的分子基础。
Mol Pharmacol. 1994 Aug;46(2):299-312.
4
Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement.人m1毒蕈碱受体结合位点的建模:实验验证与优化
J Comput Aided Mol Des. 1997 Jul;11(4):317-32. doi: 10.1023/a:1007963327888.
5
Structure and activation of muscarinic acetylcholine receptors.毒蕈碱型乙酰胆碱受体的结构与激活
Biochem Soc Trans. 2003 Feb;31(Pt 1):29-34. doi: 10.1042/bst0310029.
6
The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.M1 毒蕈碱型乙酰胆碱受体变构激动剂 AC-42 和 1-[1'-(2-甲基苄基)-1,4'-联哌啶-4-基]-1,3-二氢-2H-苯并咪唑-2-酮与乙酰胆碱正位构象结合位点不同的独特结合位点结合。
Mol Pharmacol. 2010 Oct;78(4):648-57. doi: 10.1124/mol.110.065771. Epub 2010 Jul 21.
7
Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors.m1-毒素1的定点诱变:负责毒素与M(1)毒蕈碱受体稳定结合的两个氨基酸
Mol Pharmacol. 2001 Oct;60(4):725-31.
8
Recognition of cholinergic agonists by the muscarinic receptor. 1. Acetylcholine and other agonists with the NCCOCC backbone.毒蕈碱受体对胆碱能激动剂的识别。1. 乙酰胆碱及其他具有NCCOCC主链的激动剂。
J Med Chem. 1983 Jun;26(6):817-23. doi: 10.1021/jm00360a007.
9
Theoretical quantitative structure-activity relationship analysis on three dimensional models of ligand-m1 muscarinic receptor complexes.配体 - m1毒蕈碱受体复合物三维模型的理论定量构效关系分析
Bioorg Med Chem. 1994 Mar;2(3):195-211. doi: 10.1016/s0968-0896(00)82015-5.
10
The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.结合激动剂或拮抗剂的人M1毒蕈碱型乙酰胆碱受体的预测三维结构。
ChemMedChem. 2006 Aug;1(8):878-90. doi: 10.1002/cmdc.200600047.

引用本文的文献

1
Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.通过定点诱变和分子模拟探索人5-羟色胺(4)受体的配体结合位点。
Br J Pharmacol. 2000 Jun;130(3):527-38. doi: 10.1038/sj.bjp.0703356.
2
Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors.苏氨酸192和天冬酰胺382在激动剂和拮抗剂与M1毒蕈碱受体相互作用中的作用。
Br J Pharmacol. 1999 Feb;126(3):735-45. doi: 10.1038/sj.bjp.0702301.
3
Molecular probes for muscarinic receptors: functionalized congeners of selective muscarinic antagonists.
毒蕈碱受体的分子探针:选择性毒蕈碱拮抗剂的功能化类似物。
Life Sci. 1995;56(11-12):823-30. doi: 10.1016/0024-3205(95)00016-y.
4
BUNDLE: a program for building the transmembrane domains of G-protein-coupled receptors.BUNDLE:一个用于构建G蛋白偶联受体跨膜结构域的程序。
J Comput Aided Mol Des. 1998 Mar;12(2):111-8. doi: 10.1023/a:1007969112988.
5
Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement.人m1毒蕈碱受体结合位点的建模:实验验证与优化
J Comput Aided Mol Des. 1997 Jul;11(4):317-32. doi: 10.1023/a:1007963327888.
6
Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.诱变研究揭示了人类A2A腺苷受体与生物胺G蛋白偶联受体之间的结构-活性相似性。
J Med Chem. 1997 Aug 1;40(16):2588-95. doi: 10.1021/jm970084v.
7
Delineation of the peptide binding site of the human galanin receptor.人甘丙肽受体肽结合位点的描绘
EMBO J. 1996 Jan 15;15(2):236-44.
8
Automated method for modeling seven-helix transmembrane receptors from experimental data.基于实验数据对七螺旋跨膜受体进行建模的自动化方法。
Biophys J. 1995 Dec;69(6):2419-42. doi: 10.1016/S0006-3495(95)80112-8.
9
A computer modeling postulated mechanism for angiotensin II receptor activation.
J Protein Chem. 1995 Jul;14(5):381-98. doi: 10.1007/BF01886795.
10
Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor.腺苷受体的分子建模。大鼠腺苷A2A受体上的配体结合位点。
Eur J Pharmacol. 1994 Jun 15;268(1):95-104. doi: 10.1016/0922-4106(94)90124-4.